<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03567603</url>
  </required_header>
  <id_info>
    <org_study_id>RSRB#72329</org_study_id>
    <nct_id>NCT03567603</nct_id>
  </id_info>
  <brief_title>Sound Processing Changes in Babies With Opioid Exposure</brief_title>
  <official_title>A Comparison of Mismatch Negativity Waveform Differences in Opioid-exposed and Non-exposed Neonates.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify problems with interpreting sounds in babies that
      have been exposed to opioids prior to birth. Being able to identify these issues in infancy
      may allow us to find children who may have problems with language learning later in life so
      that we can try to minimize these.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 25, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent with neonates with auditory cortical processing deficiencies</measure>
    <time_frame>baseline</time_frame>
    <description>A bone conducting sound playback lead will be placed over a bony prominence on the skull to transmit the auditory oddball paradigm that will be repeatedly played via this lead. The oddball paradigm will consist of a repeating sound loop including multiple identical 5-30 decibels tones of same duration interspersed with single 5-30 decibels tone of different pitch but same duration (deviant tone). Continuous EEG recordings will be collected during playback.
EEG tracings will be analyzed specifically for the mismatch negativity waveforms. Comparisons will be made between the deviant and standard responses (sound tones) and the percentage of neonates with no difference between the standard and deviant waveforms will be determined.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Neonatal Abstinence Syndrome</condition>
  <arm_group>
    <arm_group_label>opioid exposed neonates</arm_group_label>
    <description>prenatal opioid exposure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-opioid exposed neonates</arm_group_label>
    <description>no prenatal opioid exposure</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Investigators with routine access to infant and maternal records will identify subjects
        based on review of patient charts upon admission to the NICU or nursery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational age ≥ 36 weeks, confirmation of dates via ultrasound or last menstrual
             period

          -  Prenatal opioid exposure (&quot;exposed&quot;), confirmed via admitted use or newborn drug
             screen; no prenatal opioid exposure (&quot;control&quot;) by maternal report or testing

          -  All races, ethnicities, sexes to be included

          -  Informed permission form signed by mother

        Exclusion Criteria:

          -  Birth weight ≤ 3rd percentile or ≥ 97th percentile for gestational age

          -  Have comorbid medical disorders including; those associated with sensorineural hearing
             loss, significant congenital anomalies, congenital heart disease, known brain
             injury/malformations

          -  Infants requiring mechanical ventilation

          -  Infants requiring continuous sedation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>20 Days</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Ronnie Guillet, MD, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Perihan Ulema, MD</last_name>
    <phone>201-328-5207</phone>
    <email>perihan_ulema@urmc.rochester.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ronnie Guillet, MD, PHD</last_name>
    <phone>585-275-6209</phone>
    <email>ronnie_guillet@urmc.rochester.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Perihan Ulema, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>June 13, 2018</study_first_submitted>
  <study_first_submitted_qc>June 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2018</study_first_posted>
  <last_update_submitted>April 22, 2020</last_update_submitted>
  <last_update_submitted_qc>April 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Ronnie Guillet</investigator_full_name>
    <investigator_title>Professor of Pediatrics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neonatal Abstinence Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

